A researcher and provider of ketamine-assisted treatments for mental health conditions,Braxia Scientific Corp. (OTC:BRAXF)has completed the acquisition of the issued and outstanding stock ofU.S.-based, private telemedicine company KetaMD Inc., with the goal of addressing mental health issues by providing access to technology-mediated ketamine treatments.
Founded by psychedelic pioneersZappy ZapolinandWarren Gumpelalong with mindfulness instructorKaia Romanand president and COOLeann Taylor, KetaMD's telemedicine platform works to provide access to safe and affordable at-home ketamine treatments for those suffering from depression and related mental health conditions across...